ATE393622T1 - System mit kontrollierter freisetzung bioaktiver wirkstoffe - Google Patents

System mit kontrollierter freisetzung bioaktiver wirkstoffe

Info

Publication number
ATE393622T1
ATE393622T1 AT03769327T AT03769327T ATE393622T1 AT E393622 T1 ATE393622 T1 AT E393622T1 AT 03769327 T AT03769327 T AT 03769327T AT 03769327 T AT03769327 T AT 03769327T AT E393622 T1 ATE393622 T1 AT E393622T1
Authority
AT
Austria
Prior art keywords
biologically active
cellulose polymer
controlled release
hydrophilic cellulose
bioactive ingredients
Prior art date
Application number
AT03769327T
Other languages
English (en)
Inventor
Jean Paul Remon
Els Mehuys
Chris Vervaet
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Application granted granted Critical
Publication of ATE393622T1 publication Critical patent/ATE393622T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT03769327T 2002-09-30 2003-09-24 System mit kontrollierter freisetzung bioaktiver wirkstoffe ATE393622T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0222612.4A GB0222612D0 (en) 2002-09-30 2002-09-30 Controlled delivery system for bioactive substances

Publications (1)

Publication Number Publication Date
ATE393622T1 true ATE393622T1 (de) 2008-05-15

Family

ID=9944998

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03769327T ATE393622T1 (de) 2002-09-30 2003-09-24 System mit kontrollierter freisetzung bioaktiver wirkstoffe

Country Status (9)

Country Link
US (1) US20060003006A1 (de)
EP (1) EP1545455B1 (de)
AT (1) ATE393622T1 (de)
AU (1) AU2003277907A1 (de)
CA (1) CA2500061A1 (de)
DE (1) DE60320661T2 (de)
ES (1) ES2305524T3 (de)
GB (1) GB0222612D0 (de)
WO (1) WO2004028503A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000076478A1 (en) 1999-06-14 2000-12-21 Cosmo S.P.A. Controlled release and taste masking oral pharmaceutical compositions
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US20050025825A1 (en) 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US8022106B2 (en) 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
WO2007056142A2 (en) * 2005-11-02 2007-05-18 Theraquest Biosciences, Llc Methods of preventing the serotonin syndrome and compositions for use therefor
US20090082466A1 (en) * 2006-01-27 2009-03-26 Najib Babul Abuse Resistant and Extended Release Formulations and Method of Use Thereof
US8329744B2 (en) * 2005-11-02 2012-12-11 Relmada Therapeutics, Inc. Methods of preventing the serotonin syndrome and compositions for use thereof
US9125833B2 (en) * 2005-11-02 2015-09-08 Relmada Therapeutics, Inc. Multimodal abuse resistant and extended release opioid formulations
US20080075771A1 (en) * 2006-07-21 2008-03-27 Vaughn Jason M Hydrophilic opioid abuse deterrent delivery system using opioid antagonists
US20080187579A1 (en) * 2007-02-01 2008-08-07 Pavan Bhat Extended-release dosage form
KR101104901B1 (ko) * 2008-05-23 2012-01-12 김영곤 능동 약물 방출형 서모 로드의 제조방법 및 이에 의해제조된 서모 로드
TWI394594B (zh) * 2009-03-06 2013-05-01 China Chemical & Pharmaceutical Co Ltd 錠劑藥學組成物及其製造方法
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
CA2804032C (en) 2010-06-30 2018-05-01 Evonik Degussa Corporation Core-sheath implant device having an inner core lobe
CN103764125A (zh) * 2011-08-30 2014-04-30 根特大学 多层释放制剂
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2015071812A1 (en) * 2013-11-18 2015-05-21 Wockhardt Limited Solid oral modified-release composition comprising budesonide or salt thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0406315B1 (de) * 1988-03-24 1992-11-11 Bukh Meditec A/S Geregelte verabreichungszusammensetzung
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
DE19539361A1 (de) * 1995-10-23 1997-04-24 Basf Ag Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
JP3565548B2 (ja) * 1997-08-29 2004-09-15 株式会社資生堂 まつ毛用化粧料
DE69917618T2 (de) * 1998-04-03 2005-06-23 Egalet A/S Zusammensetzung mit kontrollierter wirkstoff-freisetzung
CA2301042A1 (en) * 1998-06-11 1999-12-16 Em Industries, Inc. Micro-osmotic controlled drug delivery systems
FR2782006B1 (fr) * 1998-08-07 2002-04-19 Gattefosse Ets Sa Composition a liberation prolongee apte a former une micro-emulsion
SE9902742D0 (sv) * 1999-07-20 1999-07-20 Astra Ab New pharmaceutical formultion

Also Published As

Publication number Publication date
CA2500061A1 (en) 2004-04-08
AU2003277907A1 (en) 2004-04-19
DE60320661D1 (de) 2008-06-12
US20060003006A1 (en) 2006-01-05
EP1545455A1 (de) 2005-06-29
GB0222612D0 (en) 2002-11-06
WO2004028503A1 (en) 2004-04-08
EP1545455B1 (de) 2008-04-30
ES2305524T3 (es) 2008-11-01
DE60320661T2 (de) 2009-05-28

Similar Documents

Publication Publication Date Title
ATE393622T1 (de) System mit kontrollierter freisetzung bioaktiver wirkstoffe
ATE321533T1 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen
ATE267007T1 (de) Pharmazeutische tablette geeignet zur wirkstofffreisetzung in aufeinanderfolgenden und vorherbestimmbaren zeiträumen
WO2001082895A3 (en) Guaifenesin sustained release formulation and tablets
BG102313A (bg) Метод за получаване на многослойни твърди лекарствени форми за орално или ректално приложение
DE60132077D1 (de) Vitaminzusammenstellung mit verzögerter freigabe
ATE326264T1 (de) Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung
DE60038848D1 (de) Feste Arzneizusammensetzungen mit gesteuerter Wirkstoffabgabe hergestellt mittels eines Thermoformverfahrens
ATE498027T1 (de) Wirkstoffabgebende verbundkörper
EP2322146A3 (de) Mikrokapselformulierung mit zwei pharmazeutischen Wirkstoffen
FI964175A0 (fi) Hidastetusti vapauttavia matriisipellettejä ja menetelmä niiden valmistamiseksi
DE69636223D1 (de) Formulierung mit gesteuerter freisetzung für wasserlöslische arzneistoffe, in der eine auslauföffnung in situ gebildet wird
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
BR0214795A (pt) Matrizes compósitas biocompatìveis conpreendendo colágeno e elastina
ATE367803T1 (de) Subcutane implantate mit begrenzter initialer wirkstoff-freisetzung und deren anschliessende lineare veränderliche verlängerte freisetzung
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
WO2003074033A8 (en) Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
IL192611A0 (en) Biologically active composition comprising ethylcellulose
EP1608408A4 (de) Biologisch aktives material, konjugiert mit biokompatiblem polymer mit 1:1 komplex, herstellungsverfahren dafür und dieses enthaltende pharmazeutische zusammensetzung
CA2194610A1 (en) Sustained-Release Formulation of Animal Growth Hormone and Process for Preparation Thereof
WO1999047543A3 (en) Sustained-release composition including amorphous polymer
GEP20094589B (en) Orally dispersible pharmaceutical composition and process for the preparation thereof
DE50008259D1 (de) Feste pharmazeutische zubereitungen mit nanosols aus chitosan, sowie deren herstellung
ATE206911T1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
GB0021344D0 (en) Composite solid shaped articles for the controlled delivery of biologically active ingredients

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1545455

Country of ref document: EP